Publication Date:
2014-10-09
Description:
Key Points Early molecular response at 3 months can predict outcome in children treated with imatinib for CML. Children with CML may be less likely to achieve an early molecular response to imatinib than adults with CML.
Print ISSN:
0006-4971
Electronic ISSN:
1528-0020
Topics:
Biology
,
Medicine
Permalink